COMPUTE & CONNECTIVITY DESK · DISPATCH
The U.S. Department of Commerce, through the National Institute of Standards and Technology, signed seven letters of intent on 29 July 2026 committing up to US$874 million in CHIPS and Science Act research-and-development incentives. In exchange, the department said, it "will receive a minority, non-controlling equity stake in each company as a condition for receiving the funds."
GlobalFoundries drew the largest award — up to US$300 million, to pull forward domestic development of co-packaged optics by two to three years. The Register, which covered the announcement the same day, put the stake attached to it at one percent, worth roughly US$269 million. The rest of the cohort is smaller and considerably younger: Kepler (up to US$245 million, ferroelectric AI memory), Multibeam (US$140 million, advanced packaging), Extropic (US$75 million, thermodynamic sampling units), Thintronics (US$50 million, ultra-low-loss dielectrics), OBSIDIA Semiconductors (US$34 million, counterfeit and provenance detection), and Aeluma (US$30 million, indium-phosphide-free substrates).
Commerce has not published the size of any stake. One recipient has. Aeluma told the Commission in an 8-K that it "would issue equity securities to the U.S. Department of Commerce with an aggregate value equal to the award amount" — US$30 million of common stock for US$30 million of incentive. The Register put GlobalFoundries' stake at roughly US$269 million against a US$300 million award, the same ratio, though the company has not confirmed it. Where the structure is documented, this is not an incentive that carries a minority stake as a condition. It is a share purchase at par, described as a grant.
What the other five have said about the equity is nothing. Multibeam, Extropic and Thintronics each announced their awards in their own releases, and none mentions the ownership condition; Kepler and OBSIDIA have not announced at all. The condition attached to roughly US$844 million of the US$874 million is documented nowhere by the companies carrying it — visible only because one of the seven files with the SEC.
The instrument is worth separating from the amount, because the two point in different directions. The same CHIPS R&D appropriation funded companies without any ownership stake under the previous administration. Taking equity is a policy choice rather than a statutory requirement — the CHIPS Act authorizes grants, cooperative agreements and "other transactions," and does not expressly authorize the department to acquire stock. Commerce made the condition explicit in September 2025 with its "Investment Fund Path," under which recipients may be required to issue equity, warrants, intellectual-property licenses, royalties or revenue sharing to secure a return to the government.
What these seven letters are not is the moment that shift became a program. It has been one since December. On the Cato Institute's count, the CHIPS R&D Office has announced 19 final or proposed awards totaling up to US$3.8 billion across 18 companies since then — and all 19 are publicly tied to equity, with 16 still at the letter-of-intent stage. Seven more is an increment in an established practice, not a threshold crossed. Commerce itself now describes what it is doing as "a portfolio approach."
The genuine conversion story is separate, and larger. In the summer of 2025 the department turned US$5.7 billion of awarded-but-undisbursed CHIPS grants, together with US$3.2 billion committed under the Secure Enclave program, into roughly a ten percent stake in Intel. That was appropriated grant money restructured into ownership after the fact. These seven letters are not converted money — they are new money that arrives with an ownership condition already attached, which is the quieter and more durable change.
Set against the wider ledger, the sums here are modest. The Council on Foreign Relations, whose U.S. Government Deal Tracker was updated on 30 July, counts US$27.6 billion in announced investments across 37 deals since January 2025.
What the letters do not yet do is convert. They are nonbinding; NIST's release states that "there will be further diligence and approval by the Department before final awards are made," and every figure is an "up to" ceiling. Nor does GlobalFoundries' new award supersede the up-to-US$375 million quantum foundry award it received in May 2026, which carried its own proposed stake — these are two separate projects, and the government would end up holding two positions in one company.
The part worth watching is what kind of shareholder this makes Washington in companies of this size. Roughly US$269 million against GlobalFoundries is a rounding error on a public chipmaker's register. US$30 million against Aeluma — listed on Nasdaq since March 2025, and carrying US$4.67 million of revenue in its last full year — is not a rounding error on anything. Extropic's award is larger still, US$75 million, against a company whose only disclosed raise is a US$14.1 million seed from December 2023. Commerce calls every one of these stakes minority and non-controlling, and publishes no figures; the only case a company has itself confirmed shows equity issued at par with the award. Commerce argues the arrangement enhances the return to the taxpayer. The harder question, which Cato raises and the department has not answered, is what happens on the way down: a government holding equity in a company that falters has an added incentive to protect the investment with more public money. The dependency runs in both directions, and it is the direction back toward Washington that has no precedent in the CHIPS program's design.
— Capital Statecraft Intelligence · Compute & Connectivity Desk
Primary source(s): NIST press release, 29 July 2026; Aeluma, Inc. Form 8-K, 29 July 2026; Multibeam press release, 29 July 2026; Extropic press release, 30 July 2026; Thintronics press release, 30 July 2026; SEC EDGAR company search, 26 August 2026 (no registrant for Kepler Computing, Extropic, Thintronics or OBSIDIA); The Register, 29 July 2026; The Quantum Insider, 5 December 2023 (Extropic seed round); Cato Institute, 30 July 2026; Council on Foreign Relations U.S. Government Deal Tracker, 30 July 2026